Abivax SA American Depositary Shares

Stock Chart, Company Information, and Scan Results

$72.50(as of Jun 2, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Abivax SA American Depositary Shares Company Information, Fundamentals, and Technical Indicators

Stock Price$72.50
Ticker SymbolABVX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees80
CountyUSA
Market Cap$10,335.6M
EBIDTA-254.0M
10-Day Moving Average120.01
P/E Ratio-10.69
20-Day Moving Average120.62
Forward P/E Ratio0.00
50-Day Moving Average117.50
Earnings per Share-5.37
200-Day Moving Average109.59
Profit Margin-Infinity%
RSI23.59
Shares Outstanding79.7M
ATR9.61
52-Week High148.83
Volume16,036,019
52-Week Low5.69
Most Recent Support Level127.89
Book Value429.6M
Most Recent Resistance Level135.08
P/B Ratio13.38
Upper Keltner142.24
P/S RatioInfinity
Lower Keltner98.99
Debt-to-Equity Ratio142.24
Next Earnings DateUnknown
Cash Surplus415.2M
Next Ex-Dividend DateUnknown

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Abivax SA American Depositary Shares In Our Stock Scanner

As of Jun 03, 2026
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.